In conclusion, we found, for the first time, that the GADD45A (1506T>C) polymorphism may be correlated with ovarian cancer susceptibility, clinicopathological characteristics, GADD45A expression levels and ovarian cancer prognosis. This evidence concerns the gene GADD45A and ovarian cancer.